TCID | Name | Domain | Kingdom/Phylum | Protein(s) | ||
---|---|---|---|---|---|---|
1.C.3.1.1 | α-Hemolysin (alpha haemolysin; Hly; Hla; α-toxin). Fragments (13-293 aas) form heptamers like the native full length protein, but a fragment with aas 72-293 formed heptamers, octamers and nonamers. All formed Cl- permeable β-barrel channels (Vécsey-Semjén et al., 2010). The 3-d structure is available (PDB#7AHL). Both symmetry and size of cyclodextrin inhibitors and the toxin pore are important for effective inhibition (Yannakopoulou et al., 2011). Oxoxylin A inhibits hemolysis by hindering self assembly of the hepatmeric pore in which two β-strands are contributed by each subunit (Song et al. 1996; Dong et al. 2013). Applications of pore-forming α-haemolysin include small- and macromolecule-sensing, targeted cancer therapy, and drug delivery (Gurnev and Nestorovich 2014). Sugawara et al. 2015 studied pore formation. Structural comparisons among monomer, prepore and pore revealed a series of motions in which the N-terminal amino latch released upon oligomerization destroys its own key hydrogen bond betweem Asp45 and Try118. This action initiates the protrusion of the prestem. A Y118F mutant and the N-terminal truncated mutant markedly decreased the hemolytic activity, indicating the importance of the key hydrogen bond and the N-terminal amino latch for pore formation. A dynamic molecular mechanism of pore formation was proposed (Sugawara et al. 2015). Release of ATP from cells may occur directly through transmembrane pores formed by α-toxin (Baaske et al. 2016). The amino latch of staphylococcal alpha-hemolysin functions in pore formation via an co-operative interaction between the N terminus and position 217 (Jayasinghe et al. 2006). PLEKHA7 and other junctional proteins are host factors mediating death by S. aureus alpha-toxin. ADAM10 is docked to junctions by its transmembrane partner Tspan33, whose cytoplasmic C-terminus binds to the WW domain of PLEKHA7 in the presence of PDZD11. ADAM10 is locked at junctions through binding of its cytoplasmic C terminus to afadin. Junctionally clustered ADAM10 supports the efficient formation of stable toxin pores. Disruption of the PLEKHA7-PDZD11 complex inhibits ADAM10 and toxin junctional clustering. This promotes toxin pore removal from the cell surface through an actin- and macropinocytosis-dependent process, resulting in cell recovery from initial injury and survival. Thus, a dock-and-lock molecular mechanism targets ADAM10 to junctions, providing a paradigm for how junctions may regulate transmembrane receptors through their clustering (Shah et al. 2018). Airway epithelial cells are sensitivity to S. aureus α-Toxin, but the toxin heptamers are removed by extracellular vesicle formation and lysosomal degradation (Möller et al. 2021). The effect of electroosmotic solvent flow on the binding of a neutral molecule [beta-cyclodextrin (betaCD)] to sites within alpha-hemolysin pore was investigated. Mutant α-hemolysin pores were used to which betaCD can bind from either entrance and through which the direction of water flow can be controlled by choosing the charge selectivity of the pore and the polarity of the applied potential. The Kd values for betaCD for individual mutant pores varied by >100-fold with the applied potential over a range of -120 to +120 mV (Gu et al. 2003). Alpha-hemolysin can be incorporated into bicelles (Dziubak and Sęk 2023). It exhibits long-term memory with respect to ion channel kinetics (Silva et al. 2023). | Bacteria |
Bacillota | α-hemolysin of Staphylococcus aureus | ||
1.C.3.2.1 | Hemolysin II | Bacteria |
Bacillota | Hemolysin II of Bacillus cereus | ||
1.C.3.2.2 | β-toxin | Bacteria |
Bacillota | β-toxin of Clostridium perfringens | ||
1.C.3.2.3 | Cytotoxin of 336 aas and 1 N-terminal TMS. | Bacteria |
Bacillota | Cytotoxin CytK of Bacillus cereus | ||
1.C.3.2.4 | Necrotic enteritis toxin B precursor, NetB (Keyburn et al., 2008) | Bacteria |
Bacillota | NetB of Clostridium perfringens
(A8ULG6) | ||
1.C.3.2.5 | CctA (Clostridium chauvoei toxin A; 317 aas) is the main cytotoxic and haemolytic substance secreted by C. chauvoei. Vaccination of guinea pigs with CctA in the form of a fusion protein with the E. coli heat labile toxin B subunit (rCctA::LTB) as a peptide adjuvant protected the animals against challenge with spores of virulent C. chauvoei., (Frey et al. 2012). | Bacteria |
Bacillota | Cytotoxin of Clostridium chauvoei
| ||
1.C.3.2.6 | Necrotizing enteritis toxin, NetF, of 305 aas. NetF-producing type A Clostridium perfringens is an important cause of canine and foal necrotizing enteritis. NetF, related to the β-sheet pore-forming Leukocidin/Hemolysin superfamily, is considered a major virulence factor for this disease. The NetF receptor is probably a sialic acid-containing glycoprotein (Mehdizadeh Gohari et al. 2018). | Bacteria |
Bacillota | NetF of Clostridium perfringens | ||
1.C.3.3.1 | Leucocidin/Hemolysin family member, LHF | Bacteria |
Pseudomonadota | LHF member of Vibrio species Ex25, (EDN58324) | ||
1.C.3.3.2 | Leucocidin/Hemolysin toxin family member. 90% identical to a Leukocidin of Vibrio proteolyticus of 305 aas that plays an important role in virulence (Ray et al. 2016). | Bacteria |
Pseudomonadota | V12G01_16082 of Vibrio alginolyticus (Q1V718) | ||
1.C.3.4.1 | Leucocidin chain F. 3-D structures of the prepore revealed that this is substantially different from the pore structure. The structures revealed a disordered bottom half of the beta-barrel corresponding to the transmembrane region, and a rigid upper extramembrane half (Yamashita et al. 2014). LukF can form an octameric pore with 4 subunits of LukF and 4 subunits of LukS (TC# 1.C.3.4.3) (Jayasinghe and Bayley 2005). Panton-Valentine leukocidin (PVL, encoded by lukSF-PV genes) is a bi-component and pore-forming toxin carried by different staphylococcal bacteriophages (Zhao et al. 2016). The gamma-hemolysin protein is used by the pathogen to escape the immune system of the host, by assembling into octameric transmembrane pores on the surface of the target immune cell, leading to its death by leakage or apoptosis. The interactions between the individual monomers that lead to the formation of a dimer on the cell membrane, which represents the unit for further oligomerization, has not been defined. Paternoster et al. 2023 determined the stabilizing contacts that guide formation of a functional dimer. | Bacteria |
Bacillota | Leucocidin chain F (LukF) of Staphylococcus aureus (Q53747) | ||
1.C.3.4.2 | Two component β-barrel γ-haemolysin, HlgA·HlgB. Tomita et al. (2011) reported that Hlg2 and LukF form a complex, and that Hlg pores form clusters that release hemoglobin from erythrocytes. The crystal structure of this octameric pore (PDB# 3B07; 2QK7) reveals the beta-barrel pore formation mechanism by the two components (Yamashita et al., 2011). Dominant-negative mutant toxins may provide novel therapeutics to combat S. aureus infection (Reyes-Robles et al. 2016). S. aureus beta-barrel pore-forming cytotoxins, including the identification of the toxin receptors on host cells, and their roles in pathogenesis have been reviewed (Reyes-Robles and Torres 2016). | Bacteria |
Bacillota | HlgA·HlgB of Staphylococcus aureus | ||
1.C.3.4.3 | Two component β-barrel γ-haemolysin, HlgC·HlgB. HglC is identical to Leucocidin chain S (LukS) (P31716), and HlgB is identical to the HlgB protein listed under TC# 1.C.3.4.2 (Roblin et al. 2008). The pore-forming regions are initially folded up on the surfaces of the soluble precursors. To create the transmembrane pores, these regions must extend and refold into membrane-inserted beta-barrels (Tilley and Saibil 2006). | Bacteria |
Bacillota | HlgC·HlgB of Staphylococcus aureus | ||
1.C.3.4.4 | Equid-adapted leukocidin PQ, LukPQ, of 311 (LukP) and 326 aas (LukQ), respectively (Koop et al. 2017). | Bacteria |
Firmicutes | LukPQ of Staphylococcus aureus | ||
1.C.3.4.5 | Beta-channel-forming cytolysin, the synergohymenotropic toxin, of 310 aas. Bacterial infections from Staphylococcus pseudintermedius are the most common cause of skin infections (pyoderma) affecting dogs. Two component pore-forming leukocidins are a family of potent toxins secreted by staphylococci and consist of S (slow) and F (fast) components. They impair the innate immune system, the first line of defense against these pathogens. Seven different leukocidins have been characterized in Staphylococcus aureus, some of which are host and cell specific. Abouelkhair et al. 2018 identified two proteins, named "LukS-I" and "LukF-I", encoded on a degenerate prophage contained in the genome of S. pseudintermedius isolates. The killing effect of recombinant S. pseudintermedius LukS-I together with LukF-I on canine polymorphonuclear leukocytes depended on both constituents of the two-component pore-forming leukocidin. | Bacteria |
Bacillota | LukS-I/LukF-I of Staphylococcus pseudintermedius | ||
1.C.3.4.6 | Beta-channel forming cytolysin, LukNF (HlyII, hlgB, lukD, lukDv) of 327 aas. Geraniol had the highest ligand efficiency and was the most potent phyto-constituent interacting with the HlyII cytotoxin (Mohapatra et al. 2021). | Bacteria |
Bacillota | LukNF of Staphylococcus aureus | ||
1.C.3.4.7 | Leukotoxin domain protein B (plasmid) of 329 aas and 1 N-terminal TMS. | Bacteria |
Bacillota | Leukotoxin of Clostridium perfringens | ||
1.C.3.5.1 | Prostaglandin-H2 D-isomerase, PTGDS (PDS) of 190 aas and 1 N-terminal TMS. It regulates the calcium channel forming VIC family member with TC# 1.A.1.11.9 (Gomez et al. 2023). It catalyzes the conversion of PGH2 to PGD2, a prostaglandin involved in smooth muscle contraction/relaxation and a potent inhibitor of platelet aggregation (Zhou et al. 2010). It is also involved in a variety of CNS functions, such as sedation, NREM sleep and PGE2-induced allodynia, and may have an anti-apoptotic role in oligodendrocytes. Binds small non-substrate lipophilic molecules, including biliverdin, bilirubin, retinal, retinoic acid and thyroid hormone, and may act as a scavenger for harmful hydrophobic molecules and as a secretory retinoid and thyroid hormone transporter. | Eukaryota |
Metazoa, Chordata | PTGDS of Homo sapiens |